Avacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

68.50 -2.00 (-2.84%)

Bid:

68.00

Ask:

69.00

Spread: 1.00 (1.471%)

Market Cap: £320.96m

Last checked at -

Intraday Avacta Group Share Chart

REMOVE ADS

Avacta Group Hails Milestone In Multi-Affimer Production

Tue, 19th Apr 2016 09:27

LONDON (Alliance News) - Avacta Group PLC on Tuesday said it has reached a milestone on its platform development after achieving easy and high-yielding production of multi-affimer formats.

Avacta said a range of multi-meric affimer constructs central to the group's immuno-oncology programme have been successfully generated and manufactured with very strong production yields via simple production systems.

Avacta said this is a key milestone as low manufacturing yields are a common problem for biotherapeutic platforms and can lead to significant development delays.

"The ease with which we have been able to produce a wide range of important multi-affimer structures and fusion proteins is a strong validation of the affimer platform and was an important pre-clinical milestone to be achieved," said Chief Executive Alastair Smith.

Avacta shares were up 3.2% to 112.00 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance